Research ArticleArticles
Open Access

Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells

SACHIKO INUBUSHI, TOMONARI KUNIHISA, SACHIKO MIZUMOTO, SHOTARO INOUE, MAYUKO MIKI, ATSUSHI SUETSUGU, HIROKAZU TANINO and ROBERT M. HOFFMAN
Cancer Genomics & Proteomics September 2023, 20 (5) 412-416; DOI: https://doi.org/10.21873/cgp.20393

Abstract

Background/Aim: Methionine addiction is the elevated requirement for exogenous methionine for growth and survival of cancer cells, termed the Hoffman effect. Methionine-addicted cancer cells synthesize normal or excess amounts of methionine but still need an external source of methionine. Methionine restriction (MR) by either a methionine-free medium or in vivo by a low-methionine diet or by methioninase, selectively arrests cancer cells in the late S/G2 cell cycle phase, but not normal cells. The present study focuses on the comparison of production and secretion of exosomes by cancer cells under MR and normal conditions. Materials and Methods: MDA-MB-231 cells (triple-negative breast cancer), containing exosomes labeled with CD63-GFP (CD63-GFP exosomes), were visualized by fluorescence microscopy. MDA-MB-231 cells expressing exosome-specific CD63-GFP were cultured in methionine-containing (MET+) or in methionine-free (MET−) DMEM conditions. Exosomes were isolated from conditioned medium of cultured MDA-MD-231 cells by ultracentrifugation and characterized by nanoparticle tracking analysis (NTA) and Western blotting. Results: When MDA-MB-231-CD63-GFP cells were cultured under MR conditions, they arrested their growth and CD63-GFP-expressing exosomes were strongly increased in the cells. MR resulted in approximately a 2-fold increase in exosome production and secretion per cell, even though cell growth was arrested. Methionine restriction thus resulted in elevated exosome production and secretion per surviving cell. Conclusion: Exosome production and secretion in the cancer cells increased under MR, suggesting a relation between MR and exosome production and secretion.

Key Words:

Exosomes are vesicles that vary in size between 30-150 nm. Exosomes originate from endosomal membranes (1) and are produced and secreted by cancer and other cells for intercellular communication and other purposes. Methionine addiction (2-12) is a universal and fundamental hallmark of cancer termed the Hoffman effect (2-18).

Methionine addiction is due to excess transmethylation reactions in cancer cells that results in much higher requirement for methionine for growth and survival than normal cells (3, 4, 6, 7, 14, 15). Cancer cells selectively arrest in the S/G2 phases of the cell cycle after methionine restriction (16, 17).

In the present study we aimed to determine the effect of methionine restriction (MR) on exosome production and secretion in cancer cells. For imaging of exosome production in cancer cells under normal and MR conditions we previously introduced the exosome marker CD63 linked to green fluorescent protein (GFP) (CD63-GFP) to the human triple-negative breast cancer cell line MDA-MB-231, with a lentivirus vector (19). In MDA-MB-231-CD63-GFP cells, exosomes are brightly seen with GFP fluorescence. Surprising and paradoxical results of the present study show MR of MDA-MB-231-CD63-GFP cells resulted in increased production and secretion of exosomes, compared to normal-methionine conditions.

Materials and Methods

Cell line. The human breast cancer cell line, MDA-MB-231, was previously transformed to express the exosome-specific protein CD63 labeled with green fluorescent protein (CD63-GFP) (19).

The MDA-MB231-CD63-GFP cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and 100 IU/ml penicillin/streptomycin and incubated at 37°C in an atmosphere of 5% CO2 95% air. The cells were washed with phosphate-buffered saline (PBS), and the culture medium was replaced with DMEM with methionine (MET+) or without methionine (MET−) (4).

Preparation of conditioned medium and secreted exosomes. After incubation of MDA-MB-231-CD63-GFP cells for 24 h in MET+ or MET− medium, the conditioned medium (CM) was collected. Exosomes from the CM were isolated by an ultracentrifugation protocol, as reported previously (20). Briefly, the CM was centrifuged at 2,000 × g for 10 min to remove contaminating cells. The resulting supernatants were then transferred to fresh tubes and passed through a 0.22-μm filter (Millipore). The filtered CM was centrifuged for 90 min at 110,000 × g to pellet the enriched exosomes (Beckman Coulter, Brea, CA, USA). The pellets were washed with PBS and ultracentrifuged at 110,000 × g for another 90 min.

Preparation of cell lysates. Whole-cell lysates were prepared for western blotting with RIPA buffer (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) (21). After collection of the CM, the cells in culture dishes were washed with PBS and RIPA buffer. The cell lysates were measured for protein content using a Takara BCA protein assay kit (Takara, Bio Inc., Shiga, Japan).

Western blotting. Cell lysates were prepared for Western blotting as described above (21). An anti-CD63 antibody was used to quantify intracellular exosomes (BD Biosciences, Franklin Lakes, NJ, USA). Exosome particle-size analysis. Exosome size, concentration and distribution were analyzed by nanoparticle-tracking-analysis (NTA) software using a NanoSight NS500 particle counter (Malvern Panalytical Ltd., Malvern, UK). The software was optimized to identify and track each exosome particle on a frame-by-frame basis and Brownian movement was tracked and measured from frame to frame (20).

Results

Growth of MDA-MB-231-CD63-GFP cells under methionine restriction. MDA-MB-231-CD63-GFP cells were seeded in normal methionine-containing medium, then the medium was replaced with normal or methionine-restricted (MR) medium. After 24 and 48 hours the number of cells in 6 fields of view under a fluorescence microscope was counted. MDA-MB-231-CD63-GFP cells significantly arrested their growth by 24 hours (p<0.05) under methionine restriction (MR) and by 48 hours under MR there was a very large difference in cell number between the 2 groups (p<0.0005) (Figure 1).

Figure 1.
Figure 1.

Methionine addiction of MDA-MB-231-CD63-GFP cells. Bar graphs show the number of cells per microscopic field for MDA-MB-231-CD63-GFP cells at 24 and 48 h under methionine restriction and normal-methionine conditions.

Exosome production by MDA-MB-231-CD63-GFP cells under methionine restriction. MDA-MB-231-CD63 cells were cultured in normal or MR media and then observed for CD63-GFP fluorescence in the cells. MDA-MB-231-CD63-GFP showed more fluorescence under MR than under normal conditions, suggesting greater production of exosomes under MR (Figure 2). Six fields of view were analyzed for the degree of GFP brightness using a Keyence BZ-X800 fluorescence analyzer. CD63-GFP fluorescence per cell was significantly higher under MR than normal conditions and at 48 hours there was a very large increase of fluorescence under MR (p<0.005) (Figure 3).

Figure 2.
Figure 2.

Fluorescence imaging of CD63-GFP exosomes in MDA-MB-231-CD63-GFP cells under methionine restriction and normal-methionine conditions. The cell nuclei are stained with Hoechst 33342 (blue fluorescence).

Figure 3.
Figure 3.

CD63-GFP exosome fluorescence per MDA-MB-231-CD63-GFP cell under methionine restriction and normal conditions.

Production of CD63 by MDA-MB-231-CD63-GFP cells under methionine restriction. Western blotting of cell lysates showed CD63 production increased in MDA-MB-231-CD63-GFP cells under MR (Figure 4). Thus, the production of exosomes was strongly elevated in MDA-MB-231-CD63-GFP cells under MR.

Figure 4.
Figure 4.

Western blotting of CD63-GFP expression in MDA-MB-231-CD63-GFP cells under methionine restriction and normal conditions.

Secretion of exosomes by MDA-MB-231 cells under methionine restriction. In order to count the number of exosomes excreted in the medium of MDA-MB-231 cells under normal and MR conditions, exosomes were isolated by ultracentrifugation using conditioned medium collected 24 h after exposure to MR or control conditions. The ultracentrifuged exosomes were quantified by NTA counting of secreted exosome particles which showed that the exosomes particle number per cell increased under MR for 24 hours (p<0.05) (Figure 5). The exosome size was similar under MR and normal conditions (Figure 6).

Figure 5.
Figure 5.

Exosome secretion by MDA-MB-231 cells under methionine restriction [MET(−)] and normal conditions [MET(+)], as measured by a NanoSight NS500 particle counter.

Figure 6.
Figure 6.

Size of exosome particles secreted by MDA-MB-231 cells under methionine restriction [MET(−)] and normal conditions [MET(+)], as measured by a NanoSight NS500 particle counter.

Discussion

Methionine addiction of cancer cells was discovered by one of our team (RMH) (2) and is now termed the Hoffman effect (22). Cancer cells were previously found to be methionine dependent, unlike normal cells which could grow when methionine was replaced by homocysteine (23, 24). It was initially thought that cancer cells could not make methionine from homocysteine (24, 25) but later it was found that cancer cells make large amount of methionine from homocysteine (2, 3, 26). It was thus paradoxical when we showed cancer cells made more methionine from homocysteine than normal cells, but still needed external methionine for growth and survival, with the external methionine used by cancer cells for excess transmethylation reactions (3-7, 14, 15, 27). These results demonstrated methionine addiction in cancer cells (2, 3).

The present results were also surprising and paradoxical that under MR the MDA-MB231-CD63-GFP cells arrested their growth but produced and secreted much more exosomes. Why the cancer cell should expend resources on exosome production and secretion under MR where they are not able to grow and are dying is an important question and suggests a relationship between exosome production, secretion, and MR. Our current hypothesis is that the increase in exosomes production by cancer cells under MR is a stress response, Increased production of exosomes may serve as a biomarker of methionine starvation by cancer cells which may have clinical application for MR therapy (28) since exosomes can be measured in the body fluids such as tears (21). Future pre-clinical and clinical research is necessary.

Acknowledgements

This work was supported by PI Training Program for International Collaborative Research, Kobe University, 2021 and JSPS KAKENHI.

Footnotes

  • Conflicts of Interest

    The Authors declare no conflicts of interest.

  • Authors’ Contributions

    Conception and design: SI, and RMH. Performed the experiments: SI. Interpretation: TK, SM, SIn, MM, AS and HT. Manuscript writing: SI and RMH. Approval of manuscript: All Authors.

  • Received May 25, 2023.
  • Revision received July 3, 2023.
  • Accepted July 18, 2023.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

  1. ↵
    1. Valadi H,
    2. Ekström K,
    3. Bossios A,
    4. Sjöstrand M,
    5. Lee JJ,
    6. Lötvall JO
    : Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6): 654-659, 2007. DOI: 10.1038/ncb1596
    OpenUrlCrossRefPubMed
  2. ↵
    1. Hoffman RM,
    2. Erbe RW
    : High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci USA 73(5): 1523-1527, 1976. DOI: 10.1073/pnas.73.5.1523
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Wang Z,
    2. Yip LY,
    3. Lee JHJ,
    4. Wu Z,
    5. Chew HY,
    6. Chong PKW,
    7. Teo CC,
    8. Ang HY,
    9. Peh KLE,
    10. Yuan J,
    11. Ma S,
    12. Choo LSK,
    13. Basri N,
    14. Jiang X,
    15. Yu Q,
    16. Hillmer AM,
    17. Lim WT,
    18. Lim TKH,
    19. Takano A,
    20. Tan EH,
    21. Tan DSW,
    22. Ho YS,
    23. Lim B,
    24. Tam WL
    : Methionine is a metabolic dependency of tumor-initiating cells. Nat Med 25(5): 825-837, 2019. DOI: 10.1038/s41591-019-0423-5
    OpenUrlCrossRefPubMed
  4. ↵
    1. Yamamoto J,
    2. Han Q,
    3. Inubushi S,
    4. Sugisawa N,
    5. Hamada K,
    6. Nishino H,
    7. Miyake K,
    8. Kumamoto T,
    9. Matsuyama R,
    10. Bouvet M,
    11. Endo I,
    12. Hoffman RM
    : Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells. Biochem Biophys Res Commun 533(4): 1034-1038, 2020. DOI: 10.1016/j.bbrc.2020.09.108
    OpenUrlCrossRefPubMed
    1. Yamamoto J,
    2. Aoki Y,
    3. Han Q,
    4. Sugisawa N,
    5. Sun Y,
    6. Hamada K,
    7. Nishino H,
    8. Inubushi S,
    9. Miyake K,
    10. Matsuyama R,
    11. Bouvet M,
    12. Endo I,
    13. Hoffman RM
    : Reversion from methionine addiction to methionine independence results in loss of tumorigenic potential of highly-malignant lung-cancer cells. Anticancer Res 41(2): 641-643, 2021. DOI: 10.21873/anticanres.14815
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Yamamoto J,
    2. Aoki Y,
    3. Inubushi S,
    4. Han Q,
    5. Hamada K,
    6. Tashiro Y,
    7. Miyake K,
    8. Matsuyama R,
    9. Bouvet M,
    10. Clarke SG,
    11. Endo I,
    12. Hoffman RM
    : Extent and instability of trimethylation of histone H3 lysine increases with degree of malignancy and methionine addiction. Cancer Genomics Proteomics 19(1): 12-18, 2022. DOI: 10.21873/cgp.20299
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Aoki Y,
    2. Han Q,
    3. Tome Y,
    4. Yamamoto J,
    5. Kubota Y,
    6. Masaki N,
    7. Obara K,
    8. Hamada K,
    9. Wang JD,
    10. Inubushi S,
    11. Bouvet M,
    12. Clarke SG,
    13. Nishida K,
    14. Hoffman RM
    : Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation. Front Oncol 12: 1009548, 2022. DOI: 10.3389/fonc.2022.1009548
    OpenUrlCrossRefPubMed
    1. Hoffman RM,
    2. Jacobsen SJ,
    3. Erbe RW
    : Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation. Proc Natl Acad Sci USA 76(3): 1313-1317, 1979. DOI: 10.1073/pnas.76.3.1313
    OpenUrlAbstract/FREE Full Text
    1. Hoffman RM,
    2. Jacobsen SJ,
    3. Erbe RW
    : Reversion to methionine independence by malignant rat and SV40-transformed human fibroblasts. Biochem Biophys Res Commun 82(1): 228-234, 1978. DOI: 10.1016/0006-291x(78)90600-9
    OpenUrlCrossRefPubMed
    1. Kubota Y,
    2. Sato T,
    3. Hozumi C,
    4. Han Q,
    5. Aoki Y,
    6. Masaki N,
    7. Obara K,
    8. Tsunoda T,
    9. Hoffman RM
    : Superiority of [(11)C]methionine over [(18)F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer. Int J Mol Sci 24(3): 1935, 2023. DOI: 10.3390/ijms24031935
    OpenUrlCrossRefPubMed
    1. Stern PH,
    2. Wallace CD,
    3. Hoffman RM
    : Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 119(1): 29-34, 1984. DOI: 10.1002/jcp.1041190106
    OpenUrlCrossRefPubMed
  12. ↵
    1. Hoffman RM,
    2. Coalson DW,
    3. Jacobsen SJ,
    4. Erbe RW
    : Folate polyglutamate and monoglutamate accumulation in normal and SV40-transformed human fibroblasts. J Cell Physiol 109(3): 497-505, 1981. DOI: 10.1002/jcp.1041090316
    OpenUrlCrossRefPubMed
    1. Mecham JO,
    2. Rowitch D,
    3. Wallace C,
    4. Stern PH,
    5. Hoffman RM
    : The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117(2): 429-434, 1983. DOI: 10.1016/0006-291x(83)91218-4
    OpenUrlCrossRefPubMed
  14. ↵
    1. Stern PH,
    2. Hoffman RM
    : Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 20(8): 663-670, 1984. DOI: 10.1007/BF02619617
    OpenUrlCrossRefPubMed
  15. ↵
    1. Judde JG,
    2. Ellis M,
    3. Frost P
    : Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res 49(17): 4859-4865, 1989.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Hoffman RM,
    2. Jacobsen SJ
    : Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A 77(12): 7306-7310, 1980. DOI: 10.1073/pnas.77.12.7306
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Yano S,
    2. Li S,
    3. Han Q,
    4. Tan Y,
    5. Bouvet M,
    6. Fujiwara T,
    7. Hoffman RM
    : Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity. Oncotarget 5(18): 8729-8736, 2014. DOI: 10.18632/oncotarget.2369
    OpenUrlCrossRefPubMed
  18. ↵
    1. Sugimura T,
    2. Birnbaum SM,
    3. Winitz M,
    4. Greenstein JP
    : Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Arch Biochem Biophys 81(2): 448-455, 1959. DOI: 10.1016/0003-9861(59)90225-5
    OpenUrlCrossRefPubMed
  19. ↵
    1. Suetsugu A,
    2. Honma K,
    3. Saji S,
    4. Moriwaki H,
    5. Ochiya T,
    6. Hoffman RM
    : Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev 65(3): 383-390, 2013. DOI: 10.1016/j.addr.2012.08.007
    OpenUrlCrossRefPubMed
  20. ↵
    1. Otsuka K,
    2. Yamamoto Y,
    3. Ochiya T
    : Uncovering temperature-dependent extracellular vesicle secretion in breast cancer. J Extracell Vesicles 10(2): e12049, 2020.
    OpenUrl
  21. ↵
    1. Inubushi S,
    2. Kawaguchi H,
    3. Mizumoto S,
    4. Kunihisa T,
    5. Baba M,
    6. Kitayama Y,
    7. Takeuchi T,
    8. Hoffman RM,
    9. Tanino H,
    10. Sasaki R
    : Oncogenic miRNAs identified in tear exosomes from metastatic breast cancer patients. Anticancer Res 40(6): 3091-3096, 2020. DOI: 10.21873/anticanres.14290
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Kaiser P
    : Methionine dependence of cancer. Biomolecules 10(4): 568, 2020. DOI: 10.3390/biom10040568
    OpenUrlCrossRefPubMed
  23. ↵
    1. Chello PL,
    2. Bertino JR
    : Dependence of 5-methyltetrahydrofolate utilization by L5178Y murine leukemia cells in vitro on the presence of hydroxycobalamin and transcobalamin II. Cancer Res 33(8): 1898-1904, 1973.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Halpern BC,
    2. Clark BR,
    3. Hardy DN,
    4. Halpern RM,
    5. Smith RA
    : The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA 71(4): 1133-1136, 1974. DOI: 10.1073/pnas.71.4.1133
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Ashe H,
    2. Clark BR,
    3. Chu F,
    4. Hardy DN,
    5. Halpern BC,
    6. Halpern RM,
    7. Smith RA
    : N5-methyltetrahydrofolate: Homocysteine methyl transferase activity in extracts from normal, malignant and embryonic tissue culture cells. Biochem Biophys Res Commun 57(2): 417-425, 1974. DOI: 10.1016/0006-291x(74)90947-4
    OpenUrlCrossRefPubMed
  26. ↵
    1. Sullivan MR,
    2. Darnell AM,
    3. Reilly MF,
    4. Kunchok T,
    5. Joesch-cohen L,
    6. Rosenberg D,
    7. Ali A,
    8. Rees MG,
    9. Roth JA,
    10. Lewis CA,
    11. Vander Heiden MG
    : Methionine synthase is essential for cancer cell proliferation in physiological folate environments. Nat Metab 3(11): 1500-1511, 2021. DOI: 10.1038/s42255-021-00486-5
    OpenUrlCrossRef
  27. ↵
    1. Yamamoto J,
    2. Inubushi S,
    3. Han Q,
    4. Tashiro Y,
    5. Sugisawa N,
    6. Hamada K,
    7. Aoki Y,
    8. Miyake K,
    9. Matsuyama R,
    10. Bouvet M,
    11. Clarke SG,
    12. Endo I,
    13. Hoffman RM
    : Linkage of methionine addiction, histone lysine hypermethylation, and malignancy. iScience 25(4): 104162, 2022. DOI: 10.1016/j.isci.2022.104162
    OpenUrlCrossRefPubMed
  28. ↵
    1. Yamamoto J,
    2. Han Q,
    3. Simon M,
    4. Thomas D,
    5. Hoffman RM
    : Methionine Restriction: Ready for Prime Time in the Cancer Clinic? Anticancer Res 42(2): 641-644, 2022. DOI: 10.21873/anticanres.15521
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells
SACHIKO INUBUSHI, TOMONARI KUNIHISA, SACHIKO MIZUMOTO, SHOTARO INOUE, MAYUKO MIKI, ATSUSHI SUETSUGU, HIROKAZU TANINO, ROBERT M. HOFFMAN
Cancer Genomics & Proteomics Sep 2023, 20 (5) 412-416; DOI: 10.21873/cgp.20393
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords